1. Cytotoxic Effect of Bitter Melon (Momordica charantia L.) Ethanol Extract and Its Fractions on Pancreatic Cancer Cells in vitro
    Rebecca A. Richmond et al, 2017, Exploratory Research and Hypothesis in Medicine CrossRef
  2. Traditional Chinese medicine may be further explored as candidate drugs for pancreatic cancer: A review
    Yue Gao et al, 2021, Phytotherapy Research CrossRef
  3. Bitter melon juice exerts its efficacy against pancreatic cancer via targeting both bulk and cancer stem cells
    Deepanshi Dhar et al, 2018, Molecular Carcinogenesis CrossRef
  4. Emerging Antitumor Activities of the Bitter Melon (Momordica charantia)
    Evandro Fei Fang et al, 2019, Current Protein & Peptide Science CrossRef
  5. Promise of bitter melon ( Momordica charantia ) bioactives in cancer prevention and therapy
    Komal Raina et al, 2016, Seminars in Cancer Biology CrossRef
  6. Transcriptome and metabolome changes induced by bitter melon (Momordica charantia)- intake in a high-fat diet induced obesity model
    Dominique Reed et al, 2022, Journal of Traditional and Complementary Medicine CrossRef
  7. The side effects and complications of percutaneous iodine-125 seeds implantation under CT-guide for patients with advanced pancreatic cancer
    Wei-Fu Lv et al, 2017, Medicine CrossRef
  8. Bitter melon juice-intake modulates glucose metabolism and lactate efflux in tumors in its efficacy against pancreatic cancer
    Deepanshi Dhar et al, 2019, Carcinogenesis CrossRef
  9. Bitter melon juice intake with gemcitabine intervention circumvents resistance to gemcitabine in pancreatic patient‐derived xenograft tumors
    Deepanshi Dhar et al, 2020, Molecular Carcinogenesis CrossRef
  10. An anthocyanin rich strawberry extract induces apoptosis and ROS while decreases glycolysis and fibrosis in human uterine leiomyoma cells
    Md Soriful Islam et al, 2017, Oncotarget CrossRef
  11. A triterpenoid from wild bitter gourd inhibits breast cancer cells
    Li-Yuan Bai et al, 2016, Scientific Reports CrossRef
  12. Momordica charantia L.
    Marjan Talebi, 2022, Novel Drug Targets With Traditional Herbal Medicines CrossRef
  13. Effect of Momordica charantia protein on proliferation, apoptosis and the AKT signal transduction pathway in the human endometrial carcinoma Ishikawa H cell line in vitro
    Hang-Zhi Gu et al, 2017, Oncology Letters CrossRef
  14. Bitter gourd (Momordica charantia) as a rich source of bioactive components to combat cancer naturally: Are we on the right track to fully unlock its potential as inhibitor of deregulated signaling pathways
    Ammad Ahmad Farooqi et al, 2018, Food and Chemical Toxicology CrossRef
  15. Bitter Melon (Momordica Charantia), a Nutraceutical Approach for Cancer Prevention and Therapy
    Subhayan Sur et al, 2020, Cancers CrossRef
  16. Natural Products for Pancreatic Cancer Treatment: From Traditional Medicine to Modern Drug Discovery
    Ahyeon Kim et al, 2021, Nutrients CrossRef
  17. The triterpenoids of the bitter gourd (Momordica Charantia) and their pharmacological activities: A review
    Le Sun et al, 2021, Journal of Food Composition and Analysis CrossRef
  18. Disrupting cholesterol esterification by bitter melon suppresses triple‐negative breast cancer cell growth
    So Hee Shim et al, 2018, Molecular Carcinogenesis CrossRef
  19. The effects of wild bitter gourd fruit extracts on ICAM-1 expression in pulmonary epithelial cells of C57BL/6J mice and microRNA-221/222 knockout mice: Involvement of the miR-221/-222/PI3K/AKT/NF-κB pathway
    Hsin-Ching Sung et al, 2018, Phytomedicine CrossRef